These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28844639)

  • 21. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.
    Wisniewski CS; Robert S
    Ann Pharmacother; 2012; 46(7-8):1097-104. PubMed ID: 22811346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.
    Dold M; Li C; Gillies D; Leucht S
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1023-33. PubMed ID: 23602690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis.
    Zhu Y; Li C; Huhn M; Rothe P; Krause M; Bighelli I; Schneider-Thoma J; Leucht S
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):835-844. PubMed ID: 28669774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary on strategies for switching antipsychotics.
    Davis JM; Leucht S
    BMC Med; 2008 Jun; 6():18. PubMed ID: 18590521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.
    Cerovecki A; Musil R; Klimke A; Seemüller F; Haen E; Schennach R; Kühn KU; Volz HP; Riedel M
    CNS Drugs; 2013 Jul; 27(7):545-72. PubMed ID: 23821039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms.
    Shimomura Y; Kikuchi Y; Suzuki T; Uchida H; Mimura M; Takeuchi H
    Schizophr Res; 2020 Jan; 215():8-16. PubMed ID: 31784340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and strategies for switching antipsychotics.
    Ganguli R
    Am J Health Syst Pharm; 2002 Nov; 59(22 Suppl 8):S22-6. PubMed ID: 12455296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Start low, go fast? Antipsychotic titration patterns at an inpatient psychiatric hospital.
    Vadiei N; Chien J; Enwereji J; Myslinski B; Guzman A
    Ment Health Clin; 2020 Sep; 10(5):275-281. PubMed ID: 33062553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of peripheral insulin-like growth factor 1 levels in schizophrenia.
    Pejcic AV; Jankovic SM; Janjic V; Djordjic M; Milosavljevic JZ; Milosavljevic MN
    Brain Behav; 2023 Jan; 13(1):e2819. PubMed ID: 36448977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing Antipsychotic Dose Versus Switching Antipsychotic for Non Response in Schizophrenia.
    Pich J
    Issues Ment Health Nurs; 2020 Apr; 41(4):373-374. PubMed ID: 31935339
    [No Abstract]   [Full Text] [Related]  

  • 33. Antipsychotic dosing: found in translation.
    Remington G; Fervaha G; Foussias G; Agid O; Turrone P
    J Psychiatry Neurosci; 2014 Jul; 39(4):223-31. PubMed ID: 24467943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic Polypharmacy in Time Course: Evidence for a Cross-titration Trap.
    Lochmann van Bennekom MWH; Gijsman HJ; IntHout J; Verkes RJ
    J Clin Psychopharmacol; 2024 Oct; ():. PubMed ID: 39423305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability of antipsychotic transdermal patch for acute schizophrenia: a systematic review and meta-analysis.
    Kishi T; Citrome L; Sakuma K; Hamanaka S; Nishii Y; Iwata N
    Psychiatry Clin Neurosci; 2024 Apr; 78(4):260-262. PubMed ID: 38131296
    [No Abstract]   [Full Text] [Related]  

  • 36. Balancing body and mind: selecting the optimal antipsychotic.
    Siskind D; Kisely S
    Lancet; 2019 Sep; 394(10202):900-902. PubMed ID: 31526722
    [No Abstract]   [Full Text] [Related]  

  • 37. Reducing inhibition: A promising new strategy for the treatment of schizophrenia.
    Page CE; Coutellier L
    EBioMedicine; 2018 Sep; 35():25-26. PubMed ID: 30131309
    [No Abstract]   [Full Text] [Related]  

  • 38. The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.
    Leucht S; Rossum IW; Heres S; Arango C; Fleischhacker WW; Glenthøj B; Leboyer M; Leweke FM; Lewis S; McGuire P; Meyer-Lindenberg A; Rujescu D; Kapur S; Kahn RS; Sommer IE
    Focus (Am Psychiatr Publ); 2016 Jul; 14(3):378-386. PubMed ID: 31997959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic switching tool [Update].
    Aust Prescr; 2019 Dec; 42(6):213. PubMed ID: 31937995
    [No Abstract]   [Full Text] [Related]  

  • 40. Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.
    Takeuchi H; Fathi A; Thiyanavadivel S; Agid O; Remington G
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.